The market crossed US$ 1.33 billion in 2022 and is expected to hit US$ 4.02 billion by 2030, recording a CAGR of 14.8% during the forecast period
The non-invasive and minimally invasive devices segment is expected to be growing owing to its offered advantages
Increasing demand for minimally invasive treatment procedures also drives the market's growth. Dermatologists are observed to prefer treating skin problems through less invasive procedures or topical applications than surgical methods. Non-invasive body contouring is a rapidly growing field in cosmetic dermatology. Non-invasive contouring devices enhance the body's appearance by reducing excess fatty tissue, especially in areas where fat persists despite optimal diet and exercise routines. The technology can also be used for skin tightening. These devices have appeared as a popular option for surgical body contouring due to their effectiveness, favorable safety profile, minimal recovery time and reduced cost.
Within the report, the market is segmented into type, procedure, end-users, and geography. Based on type, the global body contouring devices market is bifurcated into non-invasive & minimally invasive devices and invasive devices. Based on procedure, the market is segmented into nonsurgical skin resurfacing, nonsurgical skin tightening, cellulite treatment, liposuction, and others. By end-users, market segmentation is hospitals and spa centers. Geographically, the market is sub-segmented into North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa.
Rising obesity population and associated conditions
According to CDC, in 2019, the estimated annual medical cost of obesity in the United States was USD$173 billion. Medical expenses for adults who had obesity were US$1,861 higher than medical costs for people with a healthy weight. Worldwide, obesity incidence has increased, and it is a major public health challenge, especially among young people. The most common health issue these days are obesity in children and adolescents. Before 2019, there were fewer cases of obesity than in 2021. This is especially because of diet changes in children and adolescents. The pandemic caused a lot of changes in food habits and a decrease in food availability, which is a significant risk factor for disruption in a child's physical, mental, and social well-being. Rising cases of obesity across the globe will increase the demand for body contour devices.
The growing demand for anti-aging will drive the body contouring devices market
The aging population, increasing consumer spending, and beauty consciousness support sales. It has been examined that the demand is high among people aged 30-45. Over the past decades, the declining mortality rate has given rise to the aging population all over the globe. People living longer and wanting to retain their youthful appearance positively affect global market growth. The use of skin care products has increased due to climate change and its impact on the skin. The growing number of businesses has resulted in higher levels of pollution in cities, which may have negative effects on the skin, prompting individuals to seek more skin care products for protection.
Recent strategic developments in the body contouring devices market
The body contouring devices market has undergone several significant developments, and a few of these have been mentioned below:
The body contouring devices market is driven by several players by implementing strategic activities such as investments, new launches, mergers & acquisitions, and partnerships. Allergan plc; Hologic, Inc; Bausch Health Companies Inc; Erchonia Corporation; Shanghai Fosun Pharmaceutical Group; Cutera, Inc; MicroAire Surgical Instruments; Sciton, Inc; InMode Aesthetic Solutions; and El.En. S.p.A are among the prominent players operating in the market.
The target audience for the report:
Scope of the report:
In this report, the market has been segmented based on:
The List of Companies
- Allergan plc
- Hologic, Inc
- Bausch Health Companies Inc
- Erchonia Corporation
- Shanghai Fosun Pharmaceutical Group
- Cutera, Inc
- MicroAire Surgical Instruments,
- Sciton, Inc
- InMode Aesthetic Solutions
- El.En. S.p.A.